The startup, which was founded in 2015 by former BGI employees, is developing next-generation sequencing tests for cancer applications.
Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.
BGI will work with researchers in Australia on agricultural and human health projects, and will seek new partnerships across the region.
BGI has signed an agreement to offer NRGene's bioinformatics tools as part of its agricultural genomic analysis service to customers in Asia.
Genomed, based in Warsaw, offers sequencing-based diagnostic and research services and brought BGI's noninvasive prenatal NIFTY test in house last year.
The two organizations signed a memorandum of understanding this week, following the opening of the BGI-VPC Joint Research Laboratory in 2014.
Mao Mao joined BGI Genomics in February from WuXi AppTec, where he was responsible for in vitro diagnostics product development and clinical lab services.
BGI will distribute Clearbridge's ClearCell FX1 CTC isolation technology in China and work to extend the system into new clinical and research applications.
As part of the agreement, the organizations will develop a joint Seattle-Shenzhen Institute.
The partners aim to establish and conduct programs and activities in agricultural research, technology, information transfer, and economic development.
The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.
The Los Angeles Times reports that only a third of California students meet the state's new science standards.
A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.
In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.